Details for Patent: 8,741,885
✉ Email this page to a colleague
Which drugs does patent 8,741,885 protect, and when does it expire?
Patent 8,741,885 protects XARTEMIS XR and is included in one NDA.
Summary for Patent: 8,741,885
| Title: | Gastric retentive extended release pharmaceutical compositions |
| Abstract: | The present disclosure provides extended release pharmaceutical compositions comprising an opioid and an additional active pharmaceutical ingredient, wherein the composition exhibits gastric retentive properties which are achieved by a combination of a physical property of the composition and release of the opioid, wherein upon administration to a subject, the composition has at least one pharmacokinetic parameter that differs by less than about 30% when the subject is in a fasted state as compared to a fed state. |
| Inventor(s): | Devarakonda; Krishna (St. Louis, MO), Guiliani; Michael J (Creve Coeur, MO), Gupta; Vishal K (Hillsborough, NJ), Heasley; Ralph A (Webster Groves, MO), Shelby; Susan (Creve Coeur, MO) |
| Assignee: | Mallinckrodt LLC (Hazelwood, MO) |
| Application Number: | 13/473,571 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,741,885 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; Process; Dosage form; Use; |
Drugs Protected by US Patent 8,741,885
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Inc | XARTEMIS XR | acetaminophen; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204031-001 | Mar 11, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | MANAGEMENT OF ACUTE PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
